Learn More
Abnova™ Human ABL1 (NM_005157.3, 118 a.a. - 535 a.a.) Q252H mutant Partial Recombinant Protein expressed in Sf9 cells
Shop All Abnova Corporation ProductsDescription
The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq]
Specifications
Specifications
Accession Number | NM_005157.3 |
Concentration | 0.242 ug/uL |
For Use With (Application) | Functional Study, SDS-PAGE |
Formulation | Liquid |
Gene ID (Entrez) | 25 |
Molecular Weight (g/mol) | 76.176kDa |
Name | ABL1 (Q252H) (Human) Recombinant Protein |
Preparation Method | Insect cell (Sf9) expression system |
Purification Method | GST affinity chromatography |
Quality Control Testing | 2 ug/lane SDS-PAGE Stained with Coomassie Blue |
Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.